Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma-Reference-Cited by-同舟云学术

Phase II Trial Assessing the Repeatability and Tumor Uptake of [⁶⁸Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma

Published:2024-02 Issue:2 Volume:65 Page:178-184
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Gondry Odrade,Caveliers Vicky,Xavier Catarina,Raes Laurens,Vanhoeij Marian,Verfaillie Guy,Fontaine Christel,Glorieus Katrien,De Grève Jacques,Joris Sofie,Luyten Ine,Zwaenepoel Karen,Vandenbroucke Frederik,Waelput Wim,Thyparambil Sheeno,Vaneycken Ilse,Cousaert Julie,Bourgeois Sophie,Devoogdt Nick,Goethals Lode,Everaert Hendrik,De Geeter Frank,Lahoutte Tony,Keyaerts Marleen

Publisher

Society of Nuclear Medicine

Reference38 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

3. Antibody-drug conjugates: smart chemotherapy delivery across tumor histologies;Tarantino;CA Cancer J Clin.,2022

4. Novel HER2-targeted therapies for HER2-positive metastatic breast cancer;Kunte;Cancer.,2020

5. Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions;Ferraro;Breast Cancer Res.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer;Journal of Nuclear Medicine;2024-09-05

2. Diagnostic Performance of MRI and FDG PET/CT for Preoperative Locoregional Staging of Colon Cancer: Systematic Review and Meta-Analysis;American Journal of Roentgenology;2024-09-04

3. Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress;Diagnostics;2024-09-03

4. Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer;EJNMMI Radiopharmacy and Chemistry;2024-07-24

5. Single-Domain Antibodies—Novel Tools to Study and Treat Allergies;International Journal of Molecular Sciences;2024-07-11